NCT06378229View on ClinicalTrials.gov

Psilocybin for Hospitalized Patients with Treatment-resistant Depression

PHASE2RecruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

May 21, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

December 31, 2026

Conditions

Treatment Resistant Depression

Interventions

DRUG

Psilocybin

A psychedelic drug found in certain mushrooms. It will be in a capsule of 25mg psilocybin (PEX010).

Trial Locations (1)

9000

RECRUITING

Ghent University Hospital, Ghent

Sponsors

Collaborators (1)

Filament Health Corp.

All Listed Sponsors

collaborator

Filament Health Corp.

INDUSTRY

lead

University Hospital, Ghent

OTHER